Rchr
J-GLOBAL ID：200901030691507089
Update date: Jan. 30, 2024
Murakami Yuichi
ムラカミ ユウイチ | Murakami Yuichi
Affiliation and department：
Research field (3)：
Molecular biology
, Tumor biology
, Clinical pharmacy
Research theme for competitive and other funds (3)：
- 2019 - 2022 A novel therapeutic strategy targeting SFK for overcoming osimertinib resistance in lung cancer
- 2017 - 2019 The activation of SFK contributes to the resistance to second and third generation EGFR-TKIs
- 2015 - 2017 A mechanism how mTOR inhibitor potentiate the effect of gemcitabine against pancreatic cancer
Papers (29)：
-
Yuichi Murakami, Daiki Kusakabe, Kosuke Watari, Akihiko Kawahara, Koichi Azuma, Jun Akiba, Masahiko Taniguchi, Michihiko Kuwano, Mayumi Ono. AXL/CDCP1/SRC axis confers acquired resistance to osimertinib in lung cancer. Scientific reports. 2022. 12. 1. 8983-8983
-
Kosuke Watari, Tomohiro Shibata, Hideaki Fujita, Ai Shinoda, Yuichi Murakami, Hideyuki Abe, Akihiko Kawahara, Hiroshi Ito, Jun Akiba, Shigeo Yoshida, et al. NDRG1 activates VEGF-A-induced angiogenesis through PLCγ1/ERK signaling in mouse vascular endothelial cells. Communications biology. 2020. 3. 1. 107-107
-
Tomohiro Shibata, Kosuke Watari, Akihiko Kawahara, Tomoya Sudo, Satoshi Hattori, Yuichi Murakami, Hiroto Izumi, Junji Itou, Masakazu Toi, Jun Akiba, et al. Targeting Phosphorylation of Y-Box-Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen Resistance. Molecular cancer therapeutics. 2020. 19. 3. 882-894
-
Hiroshi Ito, Kosuke Watari, Tomohiro Shibata, Tomofumi Miyamoto, Yuichi Murakami, Yukiko Nakahara, Hiroto Izumi, Hiroaki Wakimoto, Michihiko Kuwano, Tatsuya Abe, et al. Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma. Cancer research. 2020. 80. 2. 234-248
-
Yuichi Murakami, Yoshizo Kimura, Akihiko Kawahara, Shohei Mitsuyasu, Hidetoshi Miyake, Kaoru Tohyama, Yoshio Endo, Nao Yoshida, Yutaka Imamura, Kosuke Watari, et al. The augmented expression of the cytidine deaminase gene by 5-azacytidine predicts therapeutic efficacy in myelodysplastic syndromes. Oncotarget. 2019. 10. 23. 2270-2281
ｍore...
Education (3)：
- 2005 - 2008 Kyushu University Graduate School of Pharmaceutical Sciences
- 2003 - 2005 Kyushu University Graduate School of Pharmaceutical Sciences
- 1999 - 2003 Kyushu University School of Pharmaceutical Sciences
Professional career (1)：
Work history (3)：
- 2012/04 - 現在 Our Lady of Snow Social Medical Corporation St. Mary's Research Center Researcher
- 2012/04 - 2023/03 Kyushu University Graduate School of Pharmaceutical Sciences
- 2007/04 - 2012/03 Kyushu University Graduate School of Pharmaceutical Sciences Assistant Professor
Committee career (1)：
Return to Previous Page
